| Literature DB >> 2573952 |
A Bertotto1, S Crupi, C Arcangeli, R Gerli, F Scalise, G Fabietti, E Agea, R Vaccaro.
Abstract
The proliferative response of purified T cells to anti-CD2 monoclonal antibodies (T112 plus T113) was found to be markedly reduced in 12 subjects with Down's syndrome (DS). The addition of phorbol ester PMA, which activates Ca2+/phospholipid-dependent enzyme protein kinase C, or calcium ionophore A23187, which increases intracytosolic free Ca2+ concentration, enhanced, but did not normalize, the defective anti-CD2-mediated T-cell mitogenesis. In contrast, the proliferation of resting lymphocytes from trisomic patients was comparable to that of the control cells when PMA and A23187 were used as co-blastogenic reagents. Because PMA and A23187 together bypass the early activation pathways and promote T-cell growth through the direct induction of membrane interleukin 2 (IL-2) receptor expression and IL-2 synthesis and secretion, it could reasonably be hypothesized that the faulty DS T-cell activation induced by antigen or mitogen is due to a deranged transmembrane signal transduction, rather than a defect in the later intracellular events.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2573952 DOI: 10.1111/j.1365-3083.1989.tb02465.x
Source DB: PubMed Journal: Scand J Immunol ISSN: 0300-9475 Impact factor: 3.487